Abiopharma

Longeveron New MRI Biomarker Data Linking Neuroinflammation to Clinical Outcomes in Patients with Mild Alzheimer’s Disease Presented at the Clinical Trials on Alzheimer’s Disease Conference (CTAD 2025)

Smith+Nephew PLC Notification

REMINDER: Zealand Pharma’s Capital Markets Day on December 11, 2025

Pfizer Inc. - Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance

Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance

MAIA Biotechnology Announces Open Market Purchases by CEO and Directors

Cadrenal Therapeutics Appoints Dr. Lee Golden to Board of Directors

Alpha Tau to Participate in December Investor Conferences

AIM ImmunoTech to Participate in Live Fireside Chat on Virtual Investor Closing Bell Series

Clearmind Medicine Charges Forward in Alcoholism Treatment: Positive Cohort Data, Full DSMB Approval, and New Elite Site Joins the Clinical Trial